Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL
Product details
- Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL
Company announcement
American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial.
The product is being recalled due to the presence of particulate matter identified as glass and/or paraformaldehyde.
The affected product was distributed nationwide in the United States beginning September 30, 2025.
To date, American Regent, Inc. has not received any reports of adverse events related to this recall.
Risk:
The administration of an injectable product containing particulate matter may result in local irritation or swelling. The particulate matter could travel through and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. Patients with underlying cardiovascular or pulmonary compromise may be at increased risk.
Impacted states: Nationwide
Products:
- Papaverine Hydrochloride Injection, USP 60 mg/2 mL Single dose vial
Contact
For more information, call (800) 645-1706.
Related recalls
- 0.9% Sodium Chloride Injection, USP, 500 mL VIAFLEX Plastic Container
- Anticoagulant Sodium Citrate Solution USP, 250 mL VIAFLEX Plastic Container
- 70% Dextrose Injection, USP in 2000 mL VIAFLEX Plastic Container
- Thyroid Tablets, USP 30 mg
- Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial
- Excel® Lactated Ringers Injection, 1000mL